Neutralization against BA.2.75.2, BQ.1.1, and XBB from mRNA Bivalent Booster
N Engl J Med
.
2023 Jan 12;388(2):183-185.
doi: 10.1056/NEJMc2214293.
Epub 2022 Dec 21.
Authors
Meredith E Davis-Gardner
1
,
Lilin Lai
1
,
Bushra Wali
1
,
Hady Samaha
1
,
Daniel Solis
2
,
Matthew Lee
1
,
Andrea Porter-Morrison
1
,
Ian T Hentenaar
1
,
Fumiko Yamamoto
2
,
Sucheta Godbole
3
,
Yuan Liu
1
,
Daniel C Douek
3
,
Frances Eun-Hyung Lee
1
,
Nadine Rouphael
1
,
Alberto Moreno
1
,
Benjamin A Pinsky
2
,
Mehul S Suthar
4
Affiliations
1
Emory University School of Medicine, Atlanta, GA.
2
Stanford University School of Medicine, Stanford, CA.
3
National Institute of Allergy and Infectious Diseases, Bethesda, MD.
4
Emory University School of Medicine, Atlanta, GA mehul.s.suthar@emory.edu.
PMID:
36546661
PMCID:
PMC9812288
DOI:
10.1056/NEJMc2214293
No abstract available
Publication types
Letter
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Grants and funding
P51 OD011132/OD/NIH HHS/United States
75N93021C00017/AI/NIAID NIH HHS/United States
U19 AI057266/AI/NIAID NIH HHS/United States
HHSN272201400004C/AI/NIAID NIH HHS/United States
Intramural funding/AR/NIAMS NIH HHS/United States
U54 CA260563/CA/NCI NIH HHS/United States